SCHEMBL7418955

SCHEMBL7418955

COC(=O)c1ccc2cc(C)n(C(=O)OCc3ccccc3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
LMNA P02545 3/20 0.44
HPGD P15428 1/20 0.44
MAPT P10636 5/20 0.43
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RAB9A P51151 5/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 1/20 0.42
PKM P14618 2/20 0.41
NPC1 O15118 2/20 0.41
GAA P10253 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KMT2A Q03164 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417793 0.86 APOBEC3A (0.45) APOBEC3AAPOBEC3GLMNAHPGDMAPT
SCHEMBL7463560 0.86 APOBEC3A (0.43) APOBEC3AAPOBEC3GLMNAHPGDMAPT
SCHEMBL7423925 0.84 APOBEC3A (0.44) APOBEC3AAPOBEC3GLMNAHPGDMAPT
SCHEMBL7420108 0.84 APOBEC3A (0.41) APOBEC3AAPOBEC3GLMNAHPGDMAPT
SCHEMBL7170567 0.82 KDM1A (0.48) MAPTTDP1L3MBTL1RAB9AALDH1A1
SCHEMBL7166718 0.78 LMNA (0.45) LMNAHPGDMAPTTDP1L3MBTL1
SCHEMBL7214021 0.77 PARP1 (0.44) APOBEC3AAPOBEC3GLMNAHPGDMAPT
Ammonia Solution, Strong SCHEMBL27457140 0.75 KMT2A (0.57) LMNAHPGDMAPTTDP1L3MBTL1
SCHEMBL15294682 0.74 EHMT2 (0.48) LMNAHPGDMAPTRAB9ASMN1; SMN2
SCHEMBL17158280 0.72 TDP1 (0.53) LMNAHPGDMAPTTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed